tiprankstipranks
Trending News
More News >
Solid Biosciences (SLDB)
NASDAQ:SLDB
US Market

Solid Biosciences (SLDB) Financial Statements

Compare
1,579 Followers

Solid Biosciences Financial Overview

Solid Biosciences's market cap is currently $440.97M. The company's EPS TTM is $-0.48; its P/E ratio is -2.19; Solid Biosciences is scheduled to report earnings on November 3, 2025, and the estimated EPS forecast is $-0.51. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 8.09M$ 13.62M$ 0.00
Gross Profit$ -2.46M$ -2.58M$ 8.09M$ 13.62M$ -3.92M
Operating Income$ -129.73M$ -104.31M$ -106.45M$ -72.25M$ -86.46M
EBITDA$ -121.90M$ -93.43M$ -96.87M$ -69.29M$ -84.37M
Net Income$ -124.70M$ -96.02M$ -85.98M$ -72.19M$ -88.29M
Balance Sheet
Cash & Short-Term Investments$ 148.92M$ 123.64M$ 213.72M$ 207.78M$ 154.74M
Total Assets$ 188.66M$ 164.94M$ 260.25M$ 232.38M$ 171.17M
Total Debt$ 24.18M$ 26.27M$ 28.55M$ 2.06M$ 5.15M
Net Debt$ -56.06M$ -47.75M$ -126.84M$ -117.07M$ -149.59M
Total Liabilities$ 51.42M$ 38.46M$ 48.59M$ 24.17M$ 39.08M
Stockholders' Equity$ 137.25M$ 126.48M$ 211.67M$ 208.21M$ 132.09M
Cash Flow
Free Cash Flow$ -100.67M$ -95.69M$ -100.99M$ -79.05M$ -57.50M
Operating Cash Flow$ -100.01M$ -94.18M$ -97.98M$ -77.76M$ -56.60M
Investing Cash Flow$ -16.09M$ 9.69M$ 59.16M$ -91.09M$ 6.60M
Financing Cash Flow$ 122.44M$ 3.12M$ 74.83M$ 134.99M$ 128.70M
Currency in USD

Solid Biosciences Earnings and Revenue History

Solid Biosciences Debt to Assets

Solid Biosciences Cash Flow

Solid Biosciences Forecast EPS vs Actual EPS